Clinical Trial Update: Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating the efficacy of magnesium isoglycyrrhizinate to prevent chemotherapy-related acute liver injury …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Injury
• Neoplasms

Drugs mentioned

• Magnesium isoglycyrrhizinate (magnesium isoglycyrrhizinate)

Snippet

Sponsor: Cttq | Conditions: Neoplasms, Liver Injury | Phase 4 | Status: UNKNOWN